Eventide Asset Management »

Apogee Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $33M 436k 75.48

More positions owned by Eventide Asset Management

Guardant Health (GH)
Xometry Class A Com (XMTR)
Mirum Pharmaceuticals (MIRM)
Trane Technologies SHS (TT)
Beta Bionics (BBNX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Lam Research Corp Com New (LRCX)
Scholar Rock Hldg Corp (SRRK)
Axsome Therapeutics (AXSM)
Argenx Se Sponsored Adr (ARGX)
Old Dominion Freight Line (ODFL)
Targa Res Corp (TRGP)
Toast Cl A (TOST)
Collegium Pharmaceutical Inc Common Stock Usd (COLL)

View all positions for Eventide Asset Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Rtw Investments
Perceptive Advisors
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Affinity Asset Advisors
Paradigm Biocapital Advisors
Alliancebernstein
Geode Capital Management

View all funds holding Apogee Therapeutics